tetranor-PGDM结构式
|
常用名 | tetranor-PGDM | 英文名 | tetranor-PGDM |
---|---|---|---|---|
CAS号 | 70803-91-7 | 分子量 | 328.358 | |
密度 | 1.3±0.1 g/cm3 | 沸点 | 622.2±50.0 °C at 760 mmHg | |
分子式 | C16H24O7 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 344.1±26.6 °C |
tetranor-PGDM用途Tetranor PGDM是一种丰富的尿液代谢物,反映了前列腺素D2的生物合成[1]。 |
英文名 | tetranor-PGDM |
---|---|
英文别名 | 更多 |
描述 | Tetranor PGDM是一种丰富的尿液代谢物,反映了前列腺素D2的生物合成[1]。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 622.2±50.0 °C at 760 mmHg |
分子式 | C16H24O7 |
分子量 | 328.358 |
闪点 | 344.1±26.6 °C |
精确质量 | 328.152191 |
PSA | 128.97000 |
LogP | -1.38 |
蒸汽压 | 0.0±4.1 mmHg at 25°C |
折射率 | 1.522 |
~50% tetranor-PGDM 70803-91-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; Location in patent: Page/Page column 21 ; |
~% tetranor-PGDM 70803-91-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% tetranor-PGDM 70803-91-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% tetranor-PGDM 70803-91-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% tetranor-PGDM 70803-91-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% tetranor-PGDM 70803-91-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
~% tetranor-PGDM 70803-91-7 |
文献:CAYMAN CHEMICAL COMPANY, INCORPORATED; ENDRES, Gregory, W.; KORNILOV, Andriy, M.; UZIEBLO, Adam Patent: WO2011/159740 A2, 2011 ; |
tetranor-PGDM上游产品 3 | |
---|---|
tetranor-PGDM下游产品 1 | |
Cyclopentaneoctanoic acid, 2-(2-carboxyethyl)-3-hydroxy-ε,5-dioxo-, (1R,2R,3S)- |
tetranor-prostaglandin D metabolite |
8-[(1R,2R,3S)-2-(2-Carboxyethyl)-3-hydroxy-5-oxocyclopentyl]-6-oxooctanoic acid |
tetranor-prostaglandin A metabolite |